Clinical Trials Sponsored by Biomedical Advanced Research and Development Authority

Total 123 results

Biomedical Advanced Research and Development Authority

Completed

Assess the Safety & Immunogenicity of Prime-Boost Vaccination Strategies Using H5Nx Virus Vaccine Adjuvanted With AS03 or MF59

Influenza A Virus, H5N1 Subtype

United States
GlaxoSmithKline
Biomedical Advanced Research and Development Authority

Completed

Pharmacokinetics (PK) Study of Gepotidacin (GSK2140944) in Adult Subjects With Varying Degrees of Hepatic Impairment and in Matched Control Subjects With Normal Hepatic Function

Infections, Bacterial

United States
Biomedical Advanced Research and Development Authority
PPD

Completed

Assess the Safety & Immunogenicity of Stored Inactivated Influenza H5N1 Virus Vaccine Given With & Without Stored MF59 Adjuvant

A/Vietnam/H5N1 Influenza Virus

United States
Seqirus
Biomedical Advanced Research and Development Authority

Active, not recruiting

Study to Evaluate Safety and Immunogenicity of Different Priming and Booster Regimens With Adjuvanted H5N8 and/or H5N6 Influenza Vaccine in Adults

Infections | Virus Diseases | Respiratory Tract Infections | Influenza, Human | Infection Viral

United States
GlaxoSmithKline
Biomedical Advanced Research and Development Authority

Terminated

Effects of GSK2798745 on Alveolar Barrier Disruption in a Segmental Lipopolysaccharide (LPS) Challenge Model

Healthy Volunteers

Germany
Seqirus
Biomedical Advanced Research and Development Authority

Completed

A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age

Avian Influenza

United States
Vaxart
Biomedical Advanced Research and Development Authority

Completed

A Phase 2 Influenza A Challenge Study Following Oral Administration of an H1N1 HA Ad-Vector Seasonal Flu Vaccine

Influenza

United States
GlaxoSmithKline
Biomedical Advanced Research and Development Authority

Completed

Pharmacokinetic Study of Oral Gepotidacin (GSK2140944) in Subjects With Uncomplicated Urinary Tract Infection (Acute Cystitis)

Infections, Bacterial

United States
GlaxoSmithKline
Biomedical Advanced Research and Development Authority

Terminated

A Study to Assess the Effectiveness and Side Effects of GSK2798745 in Participants With Chronic Cough

Cough

United Kingdom
Evidation Health
Biomedical Advanced Research and Development Authority

Recruiting

Wearable Assisted Viral Evidence (WAVE) Study A Decentralized, Prospective Study Exploring the Relationship Between Passively-collected Data From Wearable Activity Devices and Respiratory Viral Infections (WAVE)

COVID-19 | Influenza, Human | Influenza A | Respiratory Syncytial Virus (RSV) | Influenza B

United States
Invirsa, Inc.
Biomedical Advanced Research and Development Authority

Recruiting

Study of INV-102 Ophthalmic Solution in Adults With Acute Infectious Keratoconjunctivitis

Acute Infectious Keratoconjunctivitis

United States, Thailand
T2 Biosystems
Biomedical Advanced Research and Development Authority

Active, not recruiting

T2Resistance - Detection of Resistance Related Genes

Resistance Bacterial

United States
Visterra, Inc.
Biomedical Advanced Research and Development Authority

Completed

Study of an Investigational Monoclonal Antibody, VIS410, in Subjects With Uncomplicated Influenza A

Influenza

United States, Estonia, South Africa, Bulgaria, Serbia, Ukraine, Latvia
Terumo BCTbio
Biomedical Advanced Research and Development Authority

Terminated

Efficacy of Mirasol-treated Apheresis Platelets in Patients With Hypoproliferative Thrombocytopenia (MIPLATE)

Hematologic Malignancies | Hypoproliferative Thrombocytopenia

United States
ModernaTX, Inc.
Biomedical Advanced Research and Development Authority

Completed

Safety, Tolerability, and Immunogenicity of Zika Vaccine mRNA-1893 in Healthy Flavivirus Seropositive and Seronegative Adults

Zika Virus

United States, Puerto Rico
ModernaTX, Inc.
Biomedical Advanced Research and Development Authority

Completed

Safety, Tolerability, and Immunogenicity of mRNA-1325 in Healthy Adult Subjects

Zika Virus

United States
SIGA Technologies
Biomedical Advanced Research and Development Authority

Completed

A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat (SIGA246-008)

Smallpox

United States
Invirsa, Inc.
Biomedical Advanced Research and Development Authority

Completed

Study of INV-102 Ophthalmic Solution in Adults With Moderate Symptomatic Dry Eye Disease

Dry Eye Disease

United States
Emergent BioSolutions
Biomedical Advanced Research and Development Authority

Completed

Velocity 2: An Anthrax Vaccine and Antibiotics Clinical Study

Anthrax

United States
Emergent BioSolutions
Biomedical Advanced Research and Development Authority

Completed

VELOCITY: An Anthrax Vaccine Clinical Study

Anthrax

United States
Evidation Health
Biomedical Advanced Research and Development Authority

Enrolling by invitation

Predict + Protect Study: Exploring the Effectiveness of a Predictive Health Education Intervention on the Adoption of Protective Behaviors Related to ILI

COVID-19 | Influenza | Influenza A | Respiratory Syncytial Virus (RSV) | Influenza B

United States
Biomedical Advanced Research and Development Authority
Rho, Inc.

Completed

Sublingual vs IV Atropine Bioavailability Study

Toxic Effect of Organophosphate and Carbamate Insecticides

United States
ModernaTX, Inc.
Biomedical Advanced Research and Development Authority

Completed

Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older

SARS-CoV-2

United States
SIGA Technologies
Biomedical Advanced Research and Development Authority

Withdrawn

A Phase 4, Observational Field Study to Evaluate TPOXX in Patients With Smallpox

Smallpox

United States
Genentech, Inc.
Biomedical Advanced Research and Development Authority

Completed

A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia (COVASTIL)

COVID-19 Pneumonia

United States, Spain, Brazil, Mexico
DxTerity Diagnostics
Biomedical Advanced Research and Development Authority

Completed

Gene Expression That Predicts Radiation Exposure in Humans

Total Body Irradiation

United States
Biomedical Advanced Research and Development Authority
Rho, Inc.

Completed

BARDA Securing Anthrax Immunity For the Elderly (B-SAFE)

Anthrax

United States
Biomedical Advanced Research and Development Authority
Rho, Inc.

Completed

Panblok H7 Vaccine Adjuvanted With AS03 or MF59

Influenza, Human

United States
Emergent BioSolutions
Biomedical Advanced Research and Development Authority

Completed

Study of SIAN Nasal Spray in Healthy Adults

Cyanide Poisoning

United States
ModernaTX, Inc.
Biomedical Advanced Research and Development Authority

Active, not recruiting

A Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19 (TeenCove)

SARS-CoV-2

United States, Dominican Republic
Duke University
Biomedical Advanced Research and Development Authority

Enrolling by invitation

Infection Watch Study (CovIdentify)

Respiratory Syncytial Virus Infections | COVID-19 Respiratory Infection | Influenza Viral Infections | Rhinoviral Infections

United States
Avita Medical
Biomedical Advanced Research and Development Authority

Terminated

RES® Prepared With RECELL® Compared to Standard of Care Dressings of Partial-thickness Burns in Ages 1-16 Years

Burns

United States
Current Health
Biomedical Advanced Research and Development Authority

Terminated

Risk Stratification and Early Alerting Regarding COVID-19 Hospitalization (RiskSEARCH)

Covid19

United States
Avita Medical
Biomedical Advanced Research and Development Authority

Terminated

RES Prepared With RECELL® Compared to Conventional Care for Healing of Donor Sites in Ages 1-16 Years

Skin; Deformity

United States
Cytovale, Inc.
Biomedical Advanced Research and Development Authority

Active, not recruiting

SQuISH-COVID: A Pilot Study

COVID-19 | Sepsis

United States
Bavarian Nordic
Biomedical Advanced Research and Development Authority

Completed

Freeze-Dried MVA-BN® Lot Consistency Smallpox Trial

Smallpox

United States
Altimmune, Inc.
Biomedical Advanced Research and Development Authority

Completed

NasoShield in Healthy Adults to Study Safety and Immunogenicity

Healthy Volunteers

United States
Vaxxas Pty Ltd
Biomedical Advanced Research and Development Authority

Not yet recruiting

Influenza A (H7N9) Vaccine Delivered Intradermally by High-density Microarray Patch (HD-MAP) (HD-MAP)

H7N9 Influenza

Australia
University of Rochester
Biomedical Advanced Research and Development Authority

Completed

Silverlon to Reduce Radiation Dermatitis

Radiation Dermatitis

United States
Qpex Biopharma, Inc.
Biomedical Advanced Research and Development Authority

Completed

SAD/MAD Safety and PK Study of QPX9003 (Novel Polymyxin) in Normal Healthy Volunteers (QPX9003)

Bacterial Infections

United States
Qpex Biopharma, Inc.
Biomedical Advanced Research and Development Authority

Completed

Drug-Drug Interaction Study of IV QPX2014 Combined With QPX7728 in Healthy Adult Subjects

Bacterial Infections

United States
Pharm-Olam, LLC
Biomedical Advanced Research and Development Authority

Terminated

Specimen Collection Study From Coronavirus Disease 2019 (COVID-19) Vaccinated Adults and Adolescents (CoVacSpec)

COVID-19

United States, South Africa, Colombia, Guadeloupe, India, Mexico, Puerto Rico
SIGA Technologies
PPD; Biomedical Advanced Research and Development Authority

Completed

Safety, Tolerability and PK of TPOXX in Adults Weighing More Than 120 KG

Smallpox

United States
Aptitude Medical Systems
Biomedical Advanced Research and Development Authority

Recruiting

SARS-CoV-2 and Influenza A/B in Point-of-Care and Non-Laboratory Settings

SARS-CoV-2 Infection | Influenza A | Influenza B

United States
Venatorx Pharmaceuticals, Inc.
Biomedical Advanced Research and Development Authority

Not yet recruiting

Cefepime-taniborbactam vs Meropenem in Adults With VABP or Ventilated HABP (CERTAIN-2)

Hospital-acquired Pneumonia | Ventilator-associated Pneumonia
MicuRx
Wellcome Trust; Biomedical Advanced Research and Development Authority

Completed

Study of the Safety, Tolerability, and PK of MRX-8 Administered Intravenously to HVs in SAD and MAD Cohorts

Safety

United States
SIGA Technologies
PPD; Biomedical Advanced Research and Development Authority

Completed

Drug-drug Interaction Study of TPOXX When Co-administered With Phosphate Binders

Smallpox

United States
Atox Bio Ltd
Biomedical Advanced Research and Development Authority

Completed

Phase III Efficacy and Safety Study of AB103 in the Treatment of Patients With Necrotizing Soft Tissue Infections (ACCUTE)

Necrotizing Fasciitis | Necrotizing Soft Tissue Infections | Fournier's Gangrene

United States, France
Beckman Coulter, Inc.
Biomedical Advanced Research and Development Authority

Recruiting

Sepsis Clinical Decision Support [CDS] Master Enrollment Study Protocol

Severe Sepsis | Severe Sepsis Without Septic Shock

United States
Qpex Biopharma, Inc.
Biomedical Advanced Research and Development Authority

Completed

Phase 1 Oral QPX7831 SAD and MAD in Healthy Adults

Bacterial Infections

Australia, United States

Clinical Trials Sponsored by Biomedical Advanced Research and Development Authority

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mongolia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations